Participants
malignant tumors, cancer, end-stage renal or liver disease, valvular disease
HEART, CANCER, MALIGNANT TUMORS, AMI, HEART FAILURE, AORTIC INCOMPETENCE
During the study, patients were treated with medications and underwent PCI in the hospital for AMI and were followed clinically at regular intervals after discharge. Participants were recruited through study promotional posters and hospital staff referrals. Researchers screened the participants’ medical records and conducted interviews to determine the eligibility of individuals who expressed interest in participation. Inclusion criteria: age 60–75 years; ability to use electronic equipment; ability to perform self-care, with no physical activity impairment; left ventricular ejection fraction ≥ 40%; signed informed consent provided; and willing and able to attend the complete study program without assistance. Patients were ineligible if they met any of the following exclusion criteria at screening: site researchers considered that the patient was unable to complete the study and/or attend the follow-up visits; regular practice of Ba Duan Jin, i.e., more than three sessions per week; concurrent participation in any other clinical trials; and concurrent other pathologies or malignant tumors (e.g., severe valvular disease, New York Heart Association Class IV, heart failure, severe aortic incompetence, cancer, and end-stage renal or liver disease).